Literature DB >> 22475379

Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats.

Kanaka Latha Alikatte1, Butchi Raju Akondi, Venu Gopal Yerragunta, Prabhakar Reddy Veerareddy, Suresh Palle.   

Abstract

We evaluated the Antiamnesic effects of methanolic extract of Syzygium cumini (MESC) on spatial memory impairments induced by scopolamine (1 mg/kg, i.p.), a muscarinic antagonist, using the Radial arm maze, Morris water maze, learned helpless ness tests. Effect of MESC was evaluated and compared to standard drug, piracetam (200 mg/kg, i.p.). The MESC significantly (p<0.05) improved the impairment of short term or working memory induced by scopolamine in the Radial arm maze test, and significantly (p<0.05) reversed cognitive impairments in rats as measured by the learned helplessness test. In addition, MESC decreased escape latencies in the Morris water maze test. The activity of acetylcholinesterase in the brain was inhibited significantly (p<0.05) by treatment with MESC to a level similar to that observed in rats treated with piracetam. Moreover treatment with MESC (200 and 400 mg/kg, p.o.) to scopolamine induced rats significantly (p<0.05) decreased TBARS levels which was accompanied by an increase in the activities of SOD and Catalase. MESC has dose dependent effect and 400 mg/kg dose shown more prominent results when compared to 200 mg/kg dose of MESC. These results indicate that MESC may exert anti-amnesic activity via inhibition of acetylcholinesterase and antioxidant mechanisms in the brain.
Copyright © 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475379     DOI: 10.1016/j.braindev.2012.02.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.

Authors:  Shruti Pandey; Debapriya Garabadu
Journal:  Cell Mol Neurobiol       Date:  2016-09-01       Impact factor: 5.046

2.  An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention.

Authors:  Antoine Kavaye Kandeda; Saleh Nodeina; Symphorien Talom Mabou
Journal:  Metab Brain Dis       Date:  2022-08-02       Impact factor: 3.655

3.  Alpha lipoic acid reverses scopolamine-induced spatial memory loss and pyramidal cell neurodegeneration in the prefrontal cortex of Wistar rats.

Authors:  Adejoke Elizabeth Memudu; Rukky Precious Adanike
Journal:  IBRO Neurosci Rep       Date:  2022-05-20

Review 4.  Roles of Syzygium in Anti-Cholinesterase, Anti-Diabetic, Anti-Inflammatory, and Antioxidant: From Alzheimer's Perspective.

Authors:  Mira Syahfriena Amir Rawa; Mohd Khairul Nizam Mazlan; Rosliza Ahmad; Toshihiko Nogawa; Habibah A Wahab
Journal:  Plants (Basel)       Date:  2022-05-31

5.  Antiamnesic Effects of Walnuts Consumption on Scopolamine-Induced Memory Impairments in Rats.

Authors:  Shaahin Harandi; Leila Golchin; Mehdi Ansari; Alireza Moradi; Mohammad Shabani; Vahid Sheibani
Journal:  Basic Clin Neurosci       Date:  2015-04

6.  The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers.

Authors:  Özgür Devrim Can; Umut İrfan Üçel; Ümide Demir Özkay; Emel Ulupınar
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

7.  The effects of green Ocimum basilicum hydroalcoholic extract on retention and retrieval of memory in mice.

Authors:  Shadi Sarahroodi; Somayyeh Esmaeili; Peyman Mikaili; Zahra Hemmati; Yousof Saberi
Journal:  Anc Sci Life       Date:  2012-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.